183 related articles for article (PubMed ID: 34755412)
1. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations.
Agaram NP; Huang SC; Tap WD; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2022 Mar; 61(3):131-137. PubMed ID: 34755412
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.
Kommoss FKF; Stichel D; Mora J; Esteller M; Jones DTW; Pfister SM; Brack E; Wachtel M; Bode PK; Sinn HP; Schmidt D; Mentzel T; Kommoss F; Sahm F; von Deimling A; Koelsche C
Mod Pathol; 2021 Aug; 34(8):1558-1569. PubMed ID: 33846547
[TBL] [Abstract][Full Text] [Related]
3. Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.
Huang SC; Alaggio R; Sung YS; Chen CL; Zhang L; Kao YC; Agaram NP; Wexler LH; Antonescu CR
Am J Surg Pathol; 2016 Jul; 40(7):876-85. PubMed ID: 26872011
[TBL] [Abstract][Full Text] [Related]
4. Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.
Teot LA; Schneider M; Thorner AR; Tian J; Chi YY; Ducar M; Lin L; Wlodarski M; Grier HE; Fletcher CDM; van Hummelen P; Skapek SX; Hawkins DS; Wagers AJ; Rodriguez-Galindo C; Hettmer S
Cancer; 2018 May; 124(9):1973-1981. PubMed ID: 29461635
[TBL] [Abstract][Full Text] [Related]
5. RAS signaling dysregulation in human embryonal Rhabdomyosarcoma.
Martinelli S; McDowell HP; Vigne SD; Kokai G; Uccini S; Tartaglia M; Dominici C
Genes Chromosomes Cancer; 2009 Nov; 48(11):975-82. PubMed ID: 19681119
[TBL] [Abstract][Full Text] [Related]
6. Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.
Robbins KM; Stabley DL; Holbrook J; Sahraoui R; Sadreameli A; Conard K; Baker L; Gripp KW; Sol-Church K
Am J Med Genet A; 2016 Dec; 170(12):3197-3206. PubMed ID: 27589201
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract][Full Text] [Related]
8. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.
Nishimura R; Takita J; Sato-Otsubo A; Kato M; Koh K; Hanada R; Tanaka Y; Kato K; Maeda D; Fukayama M; Sanada M; Hayashi Y; Ogawa S
Cancer Sci; 2013 Jul; 104(7):856-64. PubMed ID: 23578105
[TBL] [Abstract][Full Text] [Related]
9. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.
Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS
Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660
[TBL] [Abstract][Full Text] [Related]
10. Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre.
Drabbe C; Benson C; Younger E; Zaidi S; Jones RL; Judson I; Chisholm J; Mandeville H; Fisher C; Thway K; Al Muderis O; Messiou C; Strauss D; Husson O; Miah A; Van der Graaf WTA
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):e27-e35. PubMed ID: 31350181
[TBL] [Abstract][Full Text] [Related]
11. Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.
Shukla N; Ameur N; Yilmaz I; Nafa K; Lau CY; Marchetti A; Borsu L; Barr FG; Ladanyi M
Clin Cancer Res; 2012 Feb; 18(3):748-57. PubMed ID: 22142829
[TBL] [Abstract][Full Text] [Related]
12. NRAS associated RASopathy and embryonal rhabdomyosarcoma.
Garren B; Stephan M; Hogue JS
Am J Med Genet A; 2020 Jan; 182(1):195-200. PubMed ID: 31697451
[TBL] [Abstract][Full Text] [Related]
13. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M
Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162
[TBL] [Abstract][Full Text] [Related]
14. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
16. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
17. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
[TBL] [Abstract][Full Text] [Related]
18. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
[TBL] [Abstract][Full Text] [Related]
19. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
[TBL] [Abstract][Full Text] [Related]
20. Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome.
Kratz CP; Steinemann D; Niemeyer CM; Schlegelberger B; Koscielniak E; Kontny U; Zenker M
Hum Mol Genet; 2007 Feb; 16(4):374-9. PubMed ID: 17164262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
